Data / Form D filings / Nacuity Pharmaceuticals, Inc.
Nacuity Pharmaceuticals, Inc.: Form D filings
Nacuity Pharmaceuticals, Inc., a pharmaceuticals company in Fort Worth, TX, filed 6 Form D notices with the SEC between 2016 and 2025. The latest, on December 30, 2025, reports $8.4 million sold of a $30 million offering to 98 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- FORT WORTH CLUB BLDG., 306 W. 7TH STREET, SUITE 310, Fort Worth, TX, 76102
- Phone
- (817) 336-3000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1690279
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | New notice | $30,000,000 | $8,393,350 | $21,606,650 | 98 | Dec 11, 2025 | sec.gov |
| Jan 3, 2022 | Amendment | $17,400,000 | $11,626,000 | $5,774,000 | 144 | Mar 16, 2021 | sec.gov |
| Mar 30, 2021 | New notice | $11,000,000 | $3,171,000 | $7,829,000 | 71 | Mar 16, 2021 | sec.gov |
| Jul 20, 2017 | Amendment | $10,000,000 | $9,227,000 | $773,000 | 125 | Jun 15, 2017 | sec.gov |
| Jun 27, 2017 | New notice | $10,000,000 | $7,310,000 | $2,690,000 | 102 | Jun 15, 2017 | sec.gov |
| Dec 8, 2016 | New notice | $2,500,000 | $1,973,000 | $527,000 | 46 | Nov 8, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Wall | Executive Officer | |
| Robin Steele | Director | |
| David Wohlberg | Executive Officer, Director | |
| Rusty Kelley | Director | |
| Gerald Cagle | Director | |
| Jami Kern | Executive Officer | |
| Benjamin Yerxa | Director | |
| Emmett Cunningham, Jr. | Director | |
| Halden Conner | Executive Officer, Director | |
| Charles Lieser | Executive Officer |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Dec 29, 2025 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Nacuity Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.